Table 1 Baseline characteristics (mean ± SD)
Sex male/female (n) | 10/3 |
|---|---|
Age (year) | 64 ± 6 |
Diabetes duration (year) | 8 ± 5 |
Diabetic values at OGTT yes/no (n) | 12/1 |
Lipid lowering drug (= statin) yes/no (n) | 8/5 |
Drugs per day | 4.3 ± 2.3 |
Anti-hypertensive drugs per day | 1.5 ± 1.5 |
Beta-blocker yes/no (n) | 4/9 |
Thiazide yes/no (n) | 4/9 |
ACE-inhibitor yes/no (n) | 5/8 |
Angiotensin-II receptor blocker yes/no (n) | 4/9 |
Calcium channel blocker yes/no (n) | 3/10 |
Anti-diabetic drugs per day | 1.2 ± 0.9 |
Metformin yes/no (n) | 9/4 |
Sulfonylurea yes/no (n) | 3/10 |
Thiazolidinedione yes/no (n) | 3/10 |
Metformin per day (mg) | 1031 ± 864 |
HbA1C (%, Mono-S) | 6.6 ± 0.6 |
Cholesterol (mmol/l) | 4.4 ± 1.1 |
LDL (mmol/l) | 2.9 ± 0.9 |
HDL (mmol/l) | 1.28 ± 0.22 |
TG (mmol/l) | 1.5 ± 0.7 |
CRP (mg/l) | 2.4 ± 1.8 |
SBP (mmHg) | 150 ± 21 |
DBP (mmHg) | 83 ± 10 |
Height (cm) | 171 ± 5 |
Weight (kg) | 87 ± 17 |
BMI (kg/m2) | 30 ± 7 |
Waist (cm) | 103 ± 14 |
fP-glucose (mmol/l) | 7.8 ± 1.2 |
fP-insulin (pmol/l) | 98 ± 44 |
AUC glucose0–120 (mmol/l·min) | 1607 ± 218 |
AUC glucose0–120 (mmol/l·min)1 | 667 ± 186 |
AUC insulin0–120 (nmol/l·min) | 30 ± 12 |
AUC insulin0–120 (nmol/l·min)1 | 18 ± 8 |
ISI0,120 (mg·l2/mmol·mU·min) | 40 ± 9 |
HOMA2 %B | 65 ± 34 |
HOMA2 %S | 59 ± 27 |
HOMA2 IR | 2.0 ± 0.8 |